| Year |
Citation |
Score |
| 2023 |
Agin-Liebes J, Hickman RA, Vonsattel JP, Faust PL, Flowers X, Utkina Sosunova I, Ntiri J, Mayeux R, Surface M, Marder K, Fahn S, Przedborski S, Alcalay RN. Patterns of TDP-43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37218402 DOI: 10.1002/mds.29449 |
0.465 |
|
| 2023 |
Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, et al. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36692014 DOI: 10.1002/mds.29288 |
0.499 |
|
| 2022 |
Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, et al. Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers. Annals of Neurology. PMID 34984729 DOI: 10.1002/ana.26302 |
0.306 |
|
| 2021 |
Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN. Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34741486 DOI: 10.1002/mds.28846 |
0.326 |
|
| 2021 |
Ortega RA, Wang C, Raymond D, Bryant N, Scherzer CR, Thaler A, Alcalay RN, West AB, Mirelman A, Kuras Y, Marder KS, Giladi N, Ozelius LJ, Bressman SB, Saunders-Pullman R. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. Jama Network Open. 4: e215845. PMID 33881531 DOI: 10.1001/jamanetworkopen.2021.5845 |
0.304 |
|
| 2020 |
Xu Y, Mirelman A, Saunders-Pullman R, Mejia-Santana H, Caccappolo E, Raymond D, Giladi N, Bressman S, Marder K, Alcalay RN. Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients. Clinical Parkinsonism & Related Disorders. 3. PMID 34095813 DOI: 10.1016/j.prdoa.2020.100042 |
0.323 |
|
| 2020 |
Dhanwani R, Pham J, Premlal ALR, Frazier A, Kumar A, Pero ME, Bartolini F, Dutra JR, Marder KS, Peters B, Sulzer D, Sette A, Lindestam Arlehamn CS. T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls. Frontiers in Neuroscience. 14: 874. PMID 32982670 DOI: 10.3389/Fnins.2020.00874 |
0.339 |
|
| 2020 |
Hickman RA, Vonsattel JP, Agin-Liebes J, Marder K, Alcalay RN. Authors' replies to the comments of Koga et al. on "Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease". Parkinsonism & Related Disorders. PMID 32928644 DOI: 10.1016/J.Parkreldis.2020.08.037 |
0.33 |
|
| 2020 |
Porciuncula F, Wasserman P, Marder KS, Rao AK. Quantifying Postural Control in Premanifest and Manifest Huntington Disease Using Wearable Sensors. Neurorehabilitation and Neural Repair. 1545968320939560. PMID 32672492 DOI: 10.1177/1545968320939560 |
0.51 |
|
| 2020 |
McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, ... ... Marder KS, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. PMID 32241955 DOI: 10.1212/Wnl.0000000000009323 |
0.382 |
|
| 2020 |
Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, et al. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathologica Communications. 8: 5. PMID 31996268 DOI: 10.1186/S40478-020-0879-Z |
0.434 |
|
| 2019 |
Agin-Liebes J, Cortes E, Vonsattel JP, Marder K, Alcalay RN. Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease. Parkinsonism & Related Disorders. PMID 31734038 DOI: 10.1016/J.Parkreldis.2019.11.006 |
0.379 |
|
| 2019 |
Alcalay RN, Kehoe C, Shorr E, Battista R, Hall A, Simuni T, Marder K, Wills AM, Naito A, Beck JC, Schwarzschild MA, Nance M. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31680121 DOI: 10.1038/S41436-019-0684-X |
0.355 |
|
| 2019 |
Agalliu I, Ortega RA, Luciano MS, Mirelman A, Pont-Sunyer C, Brockmann K, Vilas D, Tolosa E, Berg D, Warø B, Glickman A, Raymond D, Inzelberg R, Ruiz-Martinez J, Mondragon E, ... ... Marder K, et al. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31348549 DOI: 10.1002/Mds.27807 |
0.433 |
|
| 2019 |
Kozlovski T, Mitelpunkt A, Thaler A, Gurevich T, Orr-Urtreger A, Gana-Weisz M, Shachar N, Galili T, Marcus-Kalish M, Bressman S, Marder K, Giladi N, Benjamini Y, Mirelman A. Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease. Frontiers in Neurology. 10: 531. PMID 31164863 DOI: 10.3389/Fneur.2019.00531 |
0.419 |
|
| 2019 |
Anderson KE, Eberly S, Marder KS, Oakes D, Kayson E, Young A, Shoulson I. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study. Clinical Genetics. PMID 31093973 DOI: 10.1111/Cge.13529 |
0.32 |
|
| 2019 |
Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, ... ... Marder K, et al. Heritability and genetic variance of dementia with Lewy bodies. Neurobiology of Disease. PMID 30953760 DOI: 10.1016/J.Nbd.2019.04.004 |
0.396 |
|
| 2019 |
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, ... ... Marder K, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1 |
0.35 |
|
| 2019 |
Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, ... ... Marder KS, et al. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788890 DOI: 10.1002/Mds.27642 |
0.559 |
|
| 2018 |
Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, ... ... Marder K, et al. A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiology of Aging. PMID 30448004 DOI: 10.1016/J.Neurobiolaging.2018.10.019 |
0.352 |
|
| 2018 |
Zhao C, Noble JM, Marder K, Hartman JS, Gu Y, Scarmeas N. Dietary Patterns, Physical Activity, Sleep, and Risk for Dementia and Cognitive Decline. Current Nutrition Reports. PMID 30413973 DOI: 10.1007/S13668-018-0247-9 |
0.302 |
|
| 2018 |
Ortega RA, Groves M, Mirelman A, Alcalay RN, Raymond D, Elango S, Mejia-Santana H, Giladi N, Marder K, Bressman SB, Saunders-Pullman R. Evidence for increased completed suicide in first-degree relatives of G2019S mutation Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30409888 DOI: 10.1136/Jnnp-2018-319364 |
0.385 |
|
| 2018 |
Li X, Zeng D, Marder K, Wang Y. Constructing disease onset signatures using multi-dimensional network-structured biomarkers. Biostatistics (Oxford, England). PMID 30084874 DOI: 10.1093/Biostatistics/Kxy037 |
0.366 |
|
| 2018 |
Shah H, Liong C, Levy OA, Waters C, Fahn S, Marder K, Kang UJ, Wolf P, Oliva P, Zhang K, Alcalay RN, Gutierrez J. Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation: A Pilot Study. Stroke. PMID 29986930 DOI: 10.1161/Strokeaha.118.021964 |
0.351 |
|
| 2018 |
Ruskey JA, Greenbaum L, Roncière L, Alam A, Spiegelman D, Liong C, Levy OA, Waters C, Fahn S, Marder KS, Chung W, Yahalom G, Israeli-Korn S, Livneh V, Fay-Karmon T, et al. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease. European Journal of Medical Genetics. PMID 29842932 DOI: 10.1016/j.ejmg.2018.05.005 |
0.501 |
|
| 2018 |
Mirelman A, Saunders-Pullman R, Alcalay RN, Shustak S, Thaler A, Gurevich T, Raymond D, Mejia-Santana H, Orbe Reilly M, Ozelius L, Clark L, Gana-Weisz M, Bar-Shira A, Orr-Utreger A, Bressman SB, ... Marder K, et al. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29603409 DOI: 10.1002/Mds.27342 |
0.306 |
|
| 2018 |
Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, Mejia-Santana H, Orbe-Reilly M, Johannes BA, Thaler A, Ozelius L, Orr-Urtreger A, Marder KS, Giladi N, Bressman SB, et al. Progression in the LRRK2-Asssociated Parkinson Disease Population. Jama Neurology. PMID 29309488 DOI: 10.1001/Jamaneurol.2017.4019 |
0.432 |
|
| 2018 |
Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I. Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29297592 DOI: 10.1002/Mds.27239 |
0.384 |
|
| 2018 |
Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, ... ... Marder K, et al. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. The Lancet. Neurology. 17: 64-74. PMID 29263008 DOI: 10.1016/S1474-4422(17)30400-3 |
0.374 |
|
| 2017 |
San Luciano M, Wang C, Ortega RA, Giladi N, Marder K, Bressman S, Saunders-Pullman R. Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease. Annals of Clinical and Translational Neurology. 4: 801-810. PMID 29159192 DOI: 10.1002/Acn3.489 |
0.417 |
|
| 2017 |
Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, ... Marder KS, et al. Alzheimer's Disease-Related Dementias Summit 2016: National research priorities. Neurology. PMID 29117955 DOI: 10.1212/Wnl.0000000000004717 |
0.408 |
|
| 2017 |
Sklerov M, Kang UJ, Liong C, Clark L, Marder K, Pauciulo M, Nichols WC, Chung WK, Honig LS, Cortes E, Vonsattel JP, Alcalay RN. Frequency of GBA variants in autopsy-proven multiple system atrophy. Movement Disorders Clinical Practice. 4: 574-581. PMID 28966932 DOI: 10.1002/Mdc3.12481 |
0.771 |
|
| 2017 |
Lee AJ, Marder K, Alcalay RN, Mejia-Santana H, Orr-Urtreger A, Giladi N, Bressman S, Wang Y. Estimation of genetic risk function with covariates in the presence of missing genotypes. Statistics in Medicine. PMID 28656686 DOI: 10.1002/Sim.7376 |
0.369 |
|
| 2017 |
Garcia TP, Marder K. Statistical Approaches to Longitudinal Data Analysis in Neurodegenerative Diseases: Huntington's Disease as a Model. Current Neurology and Neuroscience Reports. 17: 14. PMID 28229396 DOI: 10.1007/S11910-017-0723-4 |
0.383 |
|
| 2016 |
Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I. Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease. Movement Disorders Clinical Practice. 3: 53-58. PMID 30363507 DOI: 10.1002/Mdc3.12273 |
0.383 |
|
| 2016 |
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. PMID 27913695 DOI: 10.1212/Wnl.0000000000003478 |
0.302 |
|
| 2016 |
Devanand DP, Pelton GH, D'Antonio K, Strickler JG, Kreisl WC, Noble J, Marder K, Skomorowsky A, Huey ED. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series. Alzheimer Disease and Associated Disorders. PMID 27819842 DOI: 10.1097/Wad.0000000000000161 |
0.351 |
|
| 2016 |
Swan M, Doan N, Ortega RA, Barrett M, Nichols W, Ozelius L, Soto-Valencia J, Boschung S, Deik A, Sarva H, Cabassa J, Johannes B, Raymond D, Marder K, Giladi N, et al. Neuropsychiatric characteristics of GBA-associated Parkinson disease. Journal of the Neurological Sciences. 370: 63-69. PMID 27772789 DOI: 10.1016/J.Jns.2016.08.059 |
0.417 |
|
| 2016 |
Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, et al. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiology of Aging. PMID 27666590 DOI: 10.1016/J.Neurobiolaging.2016.08.023 |
0.37 |
|
| 2016 |
Mirelman A, Bernad-Elazari H, Thaler A, Giladi-Yacobi E, Gurevich T, Gana-Weisz M, Saunders-Pullman R, Raymond D, Doan N, Bressman SB, Marder KS, Alcalay RN, Rao AK, Berg D, Brockmann K, et al. Arm swing as a potential new prodromal marker of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27430880 DOI: 10.1002/Mds.26720 |
0.603 |
|
| 2016 |
Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, ... ... Marder KS, et al. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. Npj Parkinson's Disease. 2. PMID 27110593 DOI: 10.1038/Npjparkd.2016.4 |
0.447 |
|
| 2016 |
Terrelonge M, Marder KS, Weintraub D, Alcalay RN. CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease. Journal of Molecular Neuroscience : Mn. 58: 88-92. PMID 26330275 DOI: 10.1007/S12031-015-0647-X |
0.391 |
|
| 2016 |
Liu X, Marder K, Stern Y, Dooneief G, Bell K, Todak G, Joseph M, Elsadr W, Williams JB, Ehrhardt A, Stein Z, Mayeux R. Gender Differences in HIV-Related Neurological Progression in a Cohort of Injecting Drug Users Followed for 3.5 Years. Journal of Neuro-Aids. 1: 17-30. PMID 16873176 DOI: 10.1300/J128V01N04_03 |
0.502 |
|
| 2016 |
Rao AK, Porciuncula F, Marder KS. E9 Impairment in gait speed modulation associated with functional mobility in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A48.2-A48. DOI: 10.1136/Jnnp-2016-314597.135 |
0.53 |
|
| 2015 |
Chen H, Marder K. Milk consumption and the risk of nigral degeneration. Neurology. PMID 26658908 DOI: 10.1212/Wnl.0000000000002268 |
0.383 |
|
| 2015 |
Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, et al. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases. Neurobiology of Aging. PMID 26643944 DOI: 10.1016/J.Neurobiolaging.2015.10.028 |
0.455 |
|
| 2015 |
Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736 |
0.403 |
|
| 2015 |
Wang Y, Liang B, Tong X, Marder K, Bressman S, Orr-Urtreger A, Giladi N, Zeng D. Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data. Biometrika. 102: 515-532. PMID 26412864 DOI: 10.1093/Biomet/Asv030 |
0.32 |
|
| 2015 |
Liu D, Long JD, Zhang Y, Raymond LA, Marder K, Rosser A, McCusker EA, Mills JA, Paulsen JS. Motor onset and diagnosis in Huntington disease using the diagnostic confidence level. Journal of Neurology. PMID 26410751 DOI: 10.1007/S00415-015-7900-7 |
0.352 |
|
| 2015 |
Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, Luciano MS, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N, Johannes B, Yasinovsky K, Ozelius L, Clark L, Orr-Utreger A, ... Marder K, et al. REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26366513 DOI: 10.1002/Mds.26413 |
0.358 |
|
| 2015 |
Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, ... Marder K, et al. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain : a Journal of Neurology. PMID 26117366 DOI: 10.1093/Brain/Awv179 |
0.54 |
|
| 2015 |
Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, et al. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. Plos One. 10: e0125204. PMID 25933391 DOI: 10.1371/Journal.Pone.0125204 |
0.59 |
|
| 2015 |
Mirelman A, Alcalay RN, Saunders-Pullman R, Yasinovsky K, Thaler A, Gurevich T, Mejia-Santana H, Raymond D, Gana-Weisz M, Bar-Shira A, Ozelius L, Clark L, Orr-Urtreger A, Bressman S, Marder K, et al. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 981-6. PMID 25809001 DOI: 10.1002/Mds.26213 |
0.313 |
|
| 2015 |
Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, ... ... Marder K, et al. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology. 84: 972-80. PMID 25663231 DOI: 10.1212/Wnl.0000000000001332 |
0.438 |
|
| 2015 |
Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology. 84: 880-7. PMID 25653295 DOI: 10.1212/Wnl.0000000000001315 |
0.42 |
|
| 2015 |
Helmich RC, Thaler A, van Nuenen BF, Gurevich T, Mirelman A, Marder KS, Bressman S, Orr-Urtreger A, Giladi N, Bloem BR, Toni I. Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers. Neurology. 84: 399-406. PMID 25540317 DOI: 10.1212/Wnl.0000000000001189 |
0.394 |
|
| 2015 |
Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease. Parkinsonism & Related Disorders. 21: 106-10. PMID 25434972 DOI: 10.1016/J.Parkreldis.2014.09.033 |
0.38 |
|
| 2015 |
Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. Jama Neurology. 72: 100-5. PMID 25401511 DOI: 10.1001/Jamaneurol.2014.2704 |
0.411 |
|
| 2015 |
Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, ... ... Marder KS, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/Mds.26065 |
0.53 |
|
| 2015 |
Gupte M, Alcalay RN, Mejia-Santana H, Raymond D, Saunders-Pullman R, Roos E, Orbe-Reily M, Tang MX, Mirelman A, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K. Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives. Journal of Genetic Counseling. 24: 238-46. PMID 25127731 DOI: 10.1007/S10897-014-9756-X |
0.398 |
|
| 2015 |
Seifan A, Marder KS, Mez J, Noble JM, Cortes EP, Vonsattel JP, Honig LS. Hippocampal laminar distribution of tau relates to Alzheimer's disease and age of onset. Journal of Alzheimer's Disease : Jad. 43: 315-24. PMID 25079799 DOI: 10.3233/Jad-140279 |
0.357 |
|
| 2015 |
Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K, Tang MX, Santana HM, ... ... Marder KS, et al. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Parkinsonism and Related Disorders. 21: 106-110. DOI: 10.1016/j.parkreldis.2014.09.033 |
0.474 |
|
| 2015 |
Gan-Or Z, Amshalom I, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease Journal of Neurology. 262: 2443-2447. DOI: 10.1007/S00415-015-7868-3 |
0.42 |
|
| 2014 |
Saunders-Pullman R, Mirelman A, Wang C, Alcalay RN, San Luciano M, Ortega R, Raymond D, Mejia-Santana H, Ozelius L, Clark L, Orr-Utreger A, Marder K, Giladi N, Bressman SB. Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? Annals of Clinical and Translational Neurology. 1: 670-8. PMID 25493281 DOI: 10.1002/Acn3.95 |
0.399 |
|
| 2014 |
Qin J, Garcia TP, Ma Y, Tang MX, Marder K, Wang Y. COMBINING ISOTONIC REGRESSION AND EM ALGORITHM TO PREDICT GENETIC RISK UNDER MONOTONICITY CONSTRAINT. The Annals of Applied Statistics. 8: 1182-1208. PMID 25404955 DOI: 10.1214/14-Aoas730 |
0.349 |
|
| 2014 |
Rao AK, Marder KS, Uddin J, Rakitin BC. Variability in interval production is due to timing-dependent deficits in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1516-22. PMID 25154339 DOI: 10.1002/Mds.25998 |
0.551 |
|
| 2014 |
Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology. 83: 851-60. PMID 25080517 DOI: 10.1212/Wnl.0000000000000733 |
0.388 |
|
| 2014 |
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, ... ... Marder K, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nature Genetics. 46: 989-93. PMID 25064009 DOI: 10.1038/Ng.3043 |
0.336 |
|
| 2014 |
Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, et al. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Human Molecular Genetics. 23: 6139-46. PMID 24973356 DOI: 10.1093/Hmg/Ddu334 |
0.461 |
|
| 2014 |
Vacic V, Ozelius LJ, Clark LN, Bar-Shira A, Gana-Weisz M, Gurevich T, Gusev A, Kedmi M, Kenny EE, Liu X, Mejia-Santana H, Mirelman A, Raymond D, Saunders-Pullman R, Desnick RJ, ... ... Marder K, et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Human Molecular Genetics. 23: 4693-702. PMID 24842889 DOI: 10.1093/Hmg/Ddu158 |
0.387 |
|
| 2014 |
Sharp ME, Marder KS, Côté L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 566-8. PMID 24375549 DOI: 10.1002/Mds.25792 |
0.443 |
|
| 2014 |
Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... ... Marder KS, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/Jamaneurol.2013.4498 |
0.596 |
|
| 2014 |
Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA. Tracking motor impairments in the progression of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 311-9. PMID 24150908 DOI: 10.1002/Mds.25657 |
0.345 |
|
| 2014 |
Rao A, Uddin J, Marder K, Rakitin B. I13 Variability In Interval Production Is Due To Timing Dependent Deficits In Early Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A62-A62. DOI: 10.1136/Jnnp-2014-309032.175 |
0.548 |
|
| 2014 |
Dinur T, Quinn T, Sakanaka K, Levy O, Marder KS, Waters C, Fahn S, Dorovski T, Pauciulo M, Nichols W, Rana HQ, Balwani M, Bier L, Elstein D, Zimran A, et al. Parkinson disease penetrance in patients with Gaucher disease and in glucocerebrosidase mutation carriers Molecular Genetics and Metabolism. 111: S37-S38. DOI: 10.1016/j.ymgme.2013.12.071 |
0.486 |
|
| 2013 |
Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, ... ... Marder KS, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1966-71. PMID 24243757 DOI: 10.1002/Mds.25647 |
0.583 |
|
| 2013 |
Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, Bressman S, Bar-Shira A, Orr-Urtreger A, Giladi N, Hausdorff JM, Saunders-Pullman R, Shanker VL, Groves M, Palmese C, et al. Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation Movement Disorders. 28: 1683-1690. PMID 24123150 DOI: 10.1002/Mds.25587 |
0.564 |
|
| 2013 |
Liu X, Cheng R, Ye X, Verbitsky M, Kisselev S, Mejia-Santana H, Louis E, Cote L, Andrews H, Waters C, Ford B, Fahn S, Marder K, Lee J, Clark L. Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Molecular Genetics & Genomic Medicine. 1: 142-154. PMID 24073418 DOI: 10.1002/Mgg3.18 |
0.538 |
|
| 2013 |
Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. Jama Neurology. 70: 1382-8. PMID 24000094 DOI: 10.1001/Jamaneurol.2013.3487 |
0.367 |
|
| 2013 |
Ramos EM, Latourelle JC, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Gellera C, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, ... ... Marder K, et al. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics. 14: 173-9. PMID 23644918 DOI: 10.1007/S10048-013-0364-Y |
0.326 |
|
| 2013 |
Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, ... ... Marder K, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. Jama Neurology. 70: 727-35. PMID 23588557 DOI: 10.1001/Jamaneurol.2013.1925 |
0.443 |
|
| 2013 |
Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H. Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of Disease. 52: 84-93. PMID 23220414 DOI: 10.1016/J.Nbd.2012.11.014 |
0.328 |
|
| 2013 |
Devanand D, Lee J, Luchsinger J, Manly J, Marder K, Mayeux R, Scarmeas N, Schupf N, Stern Y. Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center. Journal of Alzheimer's Disease : Jad. 33: S447-55. PMID 22836187 DOI: 10.3233/Jad-2012-129041 |
0.57 |
|
| 2012 |
Chen T, Wang Y, Ma Y, Marder K, Langbehn DR. Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease. Journal of Probability and Statistics. 2012. PMID 23476655 DOI: 10.1155/2012/375935 |
0.35 |
|
| 2012 |
van Nuenen BF, Helmich RC, Ferraye M, Thaler A, Hendler T, Orr-Urtreger A, Mirelman A, Bressman S, Marder KS, Giladi N, van de Warrenburg BP, Bloem BR, Toni I. Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. Brain : a Journal of Neurology. 135: 3687-98. PMID 23250886 DOI: 10.1093/Brain/Aws288 |
0.374 |
|
| 2012 |
Wray S, Self M, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, ... ... Marder KS, et al. Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. Plos One. 7: e43099. PMID 22952635 DOI: 10.1371/Journal.Pone.0043099 |
0.318 |
|
| 2012 |
Alcalay RN, Clark LN, Marder KS, Bradley WE. Lack of association between cancer history and PARKIN genotype: a family based study in PARKIN/Parkinson's families. Genes, Chromosomes & Cancer. 51: 1109-13. PMID 22927236 DOI: 10.1002/Gcc.21995 |
0.315 |
|
| 2012 |
Thaler A, Mirelman A, Gurevich T, Simon E, Orr-Urtreger A, Marder K, Bressman S, Giladi N. Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology. 79: 1027-32. PMID 22914834 DOI: 10.1212/Wnl.0B013E3182684646 |
0.405 |
|
| 2012 |
Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, ... ... Marder K, et al. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset. Human Genetics. 131: 1833-40. PMID 22825315 DOI: 10.1007/S00439-012-1205-Z |
0.33 |
|
| 2012 |
Marder K, Mehler MF. Development and neurodegeneration: turning HD pathogenesis on its head. Neurology. 79: 621-2. PMID 22815547 DOI: 10.1212/Wnl.0B013E3182648Bfe |
0.377 |
|
| 2012 |
Lee JH, Lee JM, Ramos EM, Gillis T, Mysore JS, Kishikawa S, Hadzi T, Hendricks AE, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Gellera C, ... ... Marder K, et al. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications. 424: 404-8. PMID 22771793 DOI: 10.1016/J.Bbrc.2012.06.120 |
0.375 |
|
| 2012 |
Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, ... ... Marder K, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Science Translational Medicine. 4: 141ra90. PMID 22764206 DOI: 10.1126/Scitranslmed.3003985 |
0.381 |
|
| 2012 |
Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of Neurology. 71: 370-84. PMID 22451204 DOI: 10.1002/Ana.22687 |
0.479 |
|
| 2012 |
Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Marder K, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/Wnl.0B013E318253D54B |
0.514 |
|
| 2012 |
Lee JM, Gillis T, Mysore JS, Ramos EM, Myers RH, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Squitieri F, Griguoli A, Di Donato S, Gomez-Tortosa E, Ayuso C, ... ... Marder K, et al. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. American Journal of Human Genetics. 90: 434-44. PMID 22387017 DOI: 10.1016/J.Ajhg.2012.01.005 |
0.343 |
|
| 2012 |
Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, ... ... Marder K, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 78: 690-5. PMID 22323755 DOI: 10.1212/Wnl.0B013E318249F683 |
0.321 |
|
| 2012 |
Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 771-4. PMID 22314772 DOI: 10.1002/Mds.24918 |
0.408 |
|
| 2012 |
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 349-56. PMID 22275317 DOI: 10.1002/Mds.24893 |
0.321 |
|
| 2012 |
Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN. Clinical and pathological characteristics of LRRK2 G2019S patients with PD. Journal of Molecular Neuroscience : Mn. 47: 139-43. PMID 22194196 DOI: 10.1007/S12031-011-9696-Y |
0.588 |
|
| 2012 |
Caccappolo E, Alcalay R, Marder K, Tang M, Rosado L, Mejia-Santana H, Ruiz D, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Louis E, Colcher A, Comella C, Siderowf A, et al. The Effect of Parkin Mutation Status on Cognitive Functioning in EOPD Patients with Long Disease Duration: The CORE-PD Study (PD7.008) Neurology. 78: PD7.008-PD7.008. DOI: 10.1212/wnl.78.1_meetingabstracts.pd7.008 |
0.497 |
|
| 2012 |
Alcalay R, Rosado L, Mejia-Santana H, Orbe-Reilly M, Caccappolo E, Tang M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Marder K, et al. Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study (IN10-2.001) Neurology. 78: IN10-2.001-IN10-2.00. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In10-2.001 |
0.526 |
|
| 2011 |
Rao AK, Mazzoni P, Wasserman P, Marder K. Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington's Disease. Plos Currents. 3: RRN1268. PMID 22008726 DOI: 10.1371/Currents.Rrn1268 |
0.52 |
|
| 2011 |
Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, ... ... Marder K, et al. The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism & Related Disorders. 17: 740-4. PMID 21856206 DOI: 10.1016/J.Parkreldis.2011.07.008 |
0.498 |
|
| 2011 |
Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. International Journal of Geriatric Psychiatry. 26: 937-43. PMID 21845596 DOI: 10.1002/Gps.2630 |
0.333 |
|
| 2011 |
Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. Bmc Medical Genetics. 12: 104. PMID 21812969 DOI: 10.1186/1471-2350-12-104 |
0.513 |
|
| 2011 |
McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, Popat RA, Costello S, Manthripragada AD, Southwick A, et al. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. Journal of the Neurological Sciences. 307: 22-9. PMID 21663922 DOI: 10.1016/J.Jns.2011.05.031 |
0.519 |
|
| 2011 |
Rao AK, Gordon AM, Marder KS. Coordination of fingertip forces during precision grip in premanifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 862-9. PMID 21394785 DOI: 10.1002/Mds.23606 |
0.514 |
|
| 2011 |
Cho SJ, Scarmeas N, Jang TW, Marder K, Tang MX, Honig LS. Importance of symptomatic cerebral infarcts on cognitive performance in patients with Alzheimer's disease. Journal of Korean Medical Science. 26: 412-6. PMID 21394311 DOI: 10.3346/Jkms.2011.26.3.412 |
0.38 |
|
| 2011 |
Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, et al. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 756-65. PMID 21281405 DOI: 10.1111/J.1468-1331.2011.03353.X |
0.513 |
|
| 2011 |
Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, ... ... Marder K, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 76: 319-26. PMID 21205674 DOI: 10.1212/Wnl.0B013E31820882Aa |
0.484 |
|
| 2011 |
Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, ... ... Marder KS, et al. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. Journal of the International Neuropsychological Society : Jins. 17: 91-100. PMID 21092386 DOI: 10.1017/S1355617710001190 |
0.569 |
|
| 2010 |
Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, ... ... Marder K, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of Neurology. 67: 1116-22. PMID 20837857 DOI: 10.1001/Archneurol.2010.194 |
0.571 |
|
| 2010 |
Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, Adame A, Muhammad A, Vonsattel JP, Ringe D, Cote L, Lindquist S, Masliah E, Petsko GA, Marder K, et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 16970-5. PMID 20837543 DOI: 10.1073/Pnas.1011751107 |
0.403 |
|
| 2010 |
Marder K. Tarenflurbil in patients with mild Alzheimer's disease. Current Neurology and Neuroscience Reports. 10: 336-7. PMID 20571933 DOI: 10.1007/S11910-010-0130-6 |
0.418 |
|
| 2010 |
Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Archives of Neurology. 67: 731-8. PMID 20558392 DOI: 10.1001/Archneurol.2010.95 |
0.545 |
|
| 2010 |
Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, Marder K, Stern Y, Mitsumoto H. A prospective cohort study of neuropsychological test performance in ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 312-20. PMID 20225929 DOI: 10.3109/17482961003622585 |
0.484 |
|
| 2010 |
Marder K. Cognitive impairment and dementia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. S110-6. PMID 20187235 DOI: 10.1002/Mds.22787 |
0.429 |
|
| 2010 |
Fahn S, Marder K, Côté L. Frontiers of science and clinical advances in quality of life in Parkinson's disease. Preface. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S1. PMID 20187233 DOI: 10.1002/Mds.23029 |
0.495 |
|
| 2010 |
Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, ... ... Marder KS, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 32: 775-9. PMID 20182943 DOI: 10.1080/13803390903521018 |
0.544 |
|
| 2010 |
Rao A, Gordon A, Marder K. Platform presentation—Impairments in Precision Grip Control in Pre-symptomatic Huntington's Disease Neurotherapeutics. 7: 136-136. DOI: 10.1016/J.Nurt.2009.09.026 |
0.437 |
|
| 2009 |
Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, ... ... Marder KS, et al. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Archives of Neurology. 66: 1517-22. PMID 20008657 DOI: 10.1001/Archneurol.2009.267 |
0.559 |
|
| 2009 |
Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC. Incidence of and risk factors for cognitive impairment in an early parkinson disease clinical trial cohort Neurology. 73: 1469-1477. PMID 19884574 DOI: 10.1212/Wnl.0B013E3181Bf992F |
0.425 |
|
| 2009 |
Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, ... ... Marder K, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine. 361: 1651-61. PMID 19846850 DOI: 10.1056/Nejmoa0901281 |
0.536 |
|
| 2009 |
Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y. Seizures in Alzheimer disease: who, when, and how common? Archives of Neurology. 66: 992-7. PMID 19667221 DOI: 10.1001/Archneurol.2009.130 |
0.452 |
|
| 2009 |
Rao AK, Louis ED, Marder KS. Clinical assessment of mobility and balance impairments in pre-symptomatic Huntington's disease. Gait & Posture. 30: 391-3. PMID 19647432 DOI: 10.1016/J.Gaitpost.2009.07.006 |
0.56 |
|
| 2009 |
Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology. 73: 279-86. PMID 19636047 DOI: 10.1212/Wnl.0B013E3181Af7A33 |
0.374 |
|
| 2009 |
Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K. Association of glucocerebrosidase mutations with dementia with lewy bodies. Archives of Neurology. 66: 578-83. PMID 19433657 DOI: 10.1001/Archneurol.2009.54 |
0.615 |
|
| 2009 |
Devier DJ, Pelton GH, Tabert MH, Liu X, Cuasay K, Eisenstadt R, Marder K, Stern Y, Devanand DP. The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease. International Journal of Geriatric Psychiatry. 24: 1335-42. PMID 19319929 DOI: 10.1002/Gps.2263 |
0.51 |
|
| 2009 |
Williamson J, Goldman J, Marder KS. Genetic aspects of Alzheimer disease. The Neurologist. 15: 80-6. PMID 19276785 DOI: 10.1097/Nrl.0B013E318187E76B |
0.359 |
|
| 2009 |
Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS. Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness. Gait & Posture. 29: 433-6. PMID 19111470 DOI: 10.1016/J.Gaitpost.2008.11.002 |
0.543 |
|
| 2008 |
Louis ED, Brickman AM, DeCarli C, Small SA, Marder K, Schupf N, Brown TR. Quantitative brain measurements in community-dwelling elderly persons with mild parkinsonian signs. Archives of Neurology. 65: 1649-54. PMID 19064753 DOI: 10.1001/Archneurol.2008.504 |
0.325 |
|
| 2008 |
Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T. Clinical correlates of depressive symptoms in familial Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2216-23. PMID 18785635 DOI: 10.1002/Mds.22285 |
0.356 |
|
| 2008 |
Gaba A, Zhang K, Moskowitz CB, Boozer CN, Marder K. Harris-Benedict equation estimations of energy needs as compared to measured 24-h energy expenditure by indirect calorimetry in people with early to mid-stage Huntington's disease. Nutritional Neuroscience. 11: 213-8. PMID 18782481 DOI: 10.1179/147683008X344129 |
0.316 |
|
| 2008 |
Marder K. Donepezil in patients with subcortical vascular cognitive impairment. Current Neurology and Neuroscience Reports. 8: 361-2. PMID 18713570 DOI: 10.1007/S11910-008-0056-4 |
0.377 |
|
| 2008 |
Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, et al. A novel human disease with abnormal prion protein sensitive to protease. Annals of Neurology. 63: 697-708. PMID 18571782 DOI: 10.1002/Ana.21420 |
0.39 |
|
| 2008 |
Wang Y, Clark LN, Louis ED, Mejia-Santana H, Harris J, Cote LJ, Waters C, Andrews H, Ford B, Frucht S, Fahn S, Ottman R, Rabinowitz D, Marder K. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Archives of Neurology. 65: 467-74. PMID 18413468 DOI: 10.1001/Archneur.65.4.467 |
0.565 |
|
| 2008 |
Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS. Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1100-7. PMID 18412252 DOI: 10.1002/Mds.21987 |
0.574 |
|
| 2008 |
Louis ED, Marder K, Tabert MH, Devanand DP. Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 524-30. PMID 18098296 DOI: 10.1002/Mds.21777 |
0.422 |
|
| 2008 |
Cho S, Scarmeas N, Marder K, Honig LS. P1-230: Frontal infarcts are associated with executive and language impairments in patients with Alzheimer's disease Alzheimer's & Dementia. 4: T279-T279. DOI: 10.1016/J.Jalz.2008.05.819 |
0.374 |
|
| 2007 |
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 69: 1789-99. PMID 17914061 DOI: 10.1212/01.Wnl.0000287431.88658.8B |
0.303 |
|
| 2007 |
Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 69: 1270-7. PMID 17875915 DOI: 10.1212/01.Wnl.0000276989.17578.02 |
0.499 |
|
| 2007 |
Gordon PH, Wang Y, Doorish C, Lewis M, Battista V, Mitsumoto H, Marder K. A screening assessment of cognitive impairment in patients with ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 362-5. PMID 17852014 DOI: 10.1080/17482960701500817 |
0.317 |
|
| 2007 |
Marder K. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. Current Neurology and Neuroscience Reports. 7: 363-5. PMID 17764624 DOI: 10.1007/S11910-007-0056-9 |
0.365 |
|
| 2007 |
Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J. Pooled analysis of tobacco use and risk of Parkinson disease. Archives of Neurology. 64: 990-7. PMID 17620489 DOI: 10.1001/Archneur.64.7.990 |
0.35 |
|
| 2007 |
Anderson KE, Brickman AM, Flynn J, Scarmeas N, Van Heertum R, Sackeim H, Marder KS, Bell K, Moeller JR, Stern Y. Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study. Neurology. 69: 32-41. PMID 17538034 DOI: 10.1212/01.Wnl.0000266561.47619.23 |
0.414 |
|
| 2007 |
Aarsland D, Kvaløy JT, Andersen K, Larsen JP, Tang MX, Lolk A, Kragh-Sørensen P, Marder K. The effect of age of onset of PD on risk of dementia. Journal of Neurology. 254: 38-45. PMID 17508138 DOI: 10.1007/S00415-006-0234-8 |
0.43 |
|
| 2007 |
Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Bs SJ, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, ... ... Marder K, et al. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 932-7. PMID 17415800 DOI: 10.1002/Mds.21419 |
0.56 |
|
| 2007 |
Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, et al. Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. Plos Clinical Trials. 2: e13. PMID 17401456 DOI: 10.1371/Journal.Pctr.0020013 |
0.304 |
|
| 2007 |
Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1061-8. PMID 17266092 DOI: 10.1002/Mds.21382 |
0.399 |
|
| 2007 |
Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Archives of Neurology. 64: 97-102. PMID 17210815 DOI: 10.1001/Archneur.64.1.97 |
0.453 |
|
| 2007 |
Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, et al. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement Disorders. 22: 254-257. PMID 17149721 DOI: 10.1002/Mds.21233 |
0.405 |
|
| 2007 |
Yuanjia W, Clark LN, Marder K, Rabinowitz D. Nonparametric estimation of age-at-onset distributions from censored kin-cohort data Biometrika. 94: 403-414. DOI: 10.1093/Biomet/Asm027 |
0.322 |
|
| 2006 |
Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, et al. Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease Movement Disorders. 21: 2257-2260. PMID 17078063 DOI: 10.1002/Mds.21162 |
0.353 |
|
| 2006 |
Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8 |
0.479 |
|
| 2006 |
Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 67: 1786-91. PMID 17050822 DOI: 10.1212/01.Wnl.0000244345.49809.36 |
0.494 |
|
| 2006 |
Marder K. Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study. Current Neurology and Neuroscience Reports. 6: 364-3. PMID 16928344 DOI: 10.1007/S11910-996-0015-X |
0.387 |
|
| 2006 |
Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia. 47: 867-72. PMID 16686651 DOI: 10.1111/J.1528-1167.2006.00554.X |
0.468 |
|
| 2006 |
Clark LN, Afridi S, Karlins E, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Case-control study of the parkin gene in early-onset Parkinson disease. Archives of Neurology. 63: 548-52. PMID 16606767 DOI: 10.1001/Archneur.63.4.548 |
0.547 |
|
| 2006 |
Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, Marder K, Rowland LP, Stern Y. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Archives of Neurology. 63: 345-52. PMID 16533961 DOI: 10.1001/Archneur.63.3.345 |
0.487 |
|
| 2006 |
Louis ED, Schupf N, Marder K, Tang MX. Functional correlates of mild parkinsonian signs in the community-dwelling elderly: Poor balance and inability to ambulate independently Movement Disorders. 21: 411-416. PMID 16211605 DOI: 10.1002/Mds.20735 |
0.335 |
|
| 2006 |
Marsh L, McDonald WM, Cummings J, Ravina B, Abraham N, Babcock DJ, Black KJ, Burn D, Como P, Edwards E, Elliott R, Friedman J, Gwinn-Hardy K, Hamer RM, Kelley M, ... ... Marder KS, et al. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group Movement Disorders. 21: 148-158. PMID 16211591 DOI: 10.1002/Mds.20723 |
0.374 |
|
| 2005 |
Rippon GA, Marder KS. Dementia in Parkinson's disease. Advances in Neurology. 96: 95-113. PMID 16383215 |
0.328 |
|
| 2005 |
Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology. 62: 1601-8. PMID 16216946 DOI: 10.1001/Archneur.62.10.1601 |
0.517 |
|
| 2005 |
Chatterjee A, Anderson KE, Moskowitz CB, Hauser WA, Marder KS. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 378-83. PMID 16179661 DOI: 10.1176/Jnp.17.3.378 |
0.342 |
|
| 2005 |
Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP. A 10-item smell identification scale related to risk for Alzheimer's disease. Annals of Neurology. 58: 155-60. PMID 15984022 DOI: 10.1002/Ana.20533 |
0.56 |
|
| 2005 |
Gaba AM, Zhang K, Marder K, Moskowitz CB, Werner P, Boozer CN. Energy balance in early-stage Huntington disease. The American Journal of Clinical Nutrition. 81: 1335-41. PMID 15941884 DOI: 10.1093/Ajcn/81.6.1335 |
0.323 |
|
| 2005 |
Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 64: 1696-703. PMID 15911793 DOI: 10.1212/01.Wnl.0000162054.15428.E9 |
0.523 |
|
| 2005 |
Rao AK, Quinn L, Marder KS. Reliability of spatiotemporal gait outcome measures in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1033-7. PMID 15838854 DOI: 10.1002/Mds.20482 |
0.461 |
|
| 2005 |
Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology. 64: 1157-61. PMID 15824340 DOI: 10.1212/01.Wnl.0000156157.97411.5E |
0.431 |
|
| 2005 |
Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K. Contribution of aging to the severity of different motor signs in Parkinson disease. Archives of Neurology. 62: 467-72. PMID 15767513 DOI: 10.1001/Archneur.62.3.467 |
0.558 |
|
| 2005 |
Rippon GA, Staugaitis SM, Chin SS, Goldman JE, Marder K. Corticobasal syndrome with novel argyrophilic glial inclusions. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 598-602. PMID 15726537 DOI: 10.1002/Mds.20396 |
0.318 |
|
| 2005 |
Sevigny JJ, Chin SS, Milewski Y, Albers MW, Gordon ML, Marder K. HIV encephalitis simulating Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 610-3. PMID 15704206 DOI: 10.1002/Mds.20379 |
0.325 |
|
| 2005 |
Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/Mds.20332 |
0.337 |
|
| 2005 |
Pressley JC, Tang MX, Marder K, Cote LJ, Mayeux R. Disparities in the recording of Parkinson's disease on death certificates. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 315-21. PMID 15580618 DOI: 10.1002/Mds.20339 |
0.511 |
|
| 2005 |
Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, ... Marder K, et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 100-3. PMID 15517591 DOI: 10.1002/Mds.20320 |
0.609 |
|
| 2005 |
Rao A, Muratori L, Marder K. 16.8 Factors underlying gait impairments in Huntington's disease Gait & Posture. 21: S103. DOI: 10.1016/S0966-6362(05)80338-8 |
0.522 |
|
| 2004 |
Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, ... Marder K, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology. 63: 2084-90. PMID 15596754 DOI: 10.1212/01.Wnl.0000145763.68284.15 |
0.454 |
|
| 2004 |
McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Archives of Neurology. 61: 1687-96. PMID 15534180 DOI: 10.1001/Archneur.61.11.1687 |
0.438 |
|
| 2004 |
Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y. Motor signs during the course of Alzheimer disease. Neurology. 63: 975-82. PMID 15452286 DOI: 10.1212/01.Wnl.0000138440.39918.0C |
0.534 |
|
| 2004 |
Marder K. Memantine approved to treat moderate to severe Alzheimer's disease. Current Neurology and Neuroscience Reports. 4: 349-50. PMID 15324599 DOI: 10.1007/S11910-004-0080-Y |
0.403 |
|
| 2004 |
Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Lack of familial aggregation of Parkinson disease and Alzheimer disease. Archives of Neurology. 61: 1033-9. PMID 15262733 DOI: 10.1001/Archneur.61.7.1033 |
0.575 |
|
| 2004 |
Clark LN, Afridi S, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Singleton A, Wavrant De-Vrieze F, Hardy J, Mayeux R, Fahn S, Waters C, Ford B, Frucht S, ... ... Marder K, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 796-800. PMID 15254937 DOI: 10.1002/Mds.20131 |
0.614 |
|
| 2004 |
Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101: 3498-503. PMID 14993615 DOI: 10.1073/Pnas.0308679101 |
0.333 |
|
| 2004 |
Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 60-7. PMID 14743362 DOI: 10.1002/Mds.10633 |
0.587 |
|
| 2004 |
Marder K. Vaccine trial in Alzheimer's disease is halted. Current Neurology and Neuroscience Reports. 3: 371-2. PMID 12914678 DOI: 10.1007/S11910-003-0018-9 |
0.313 |
|
| 2004 |
Pelton GH, Devanand D, Padilla M, Juszczak N, Chen C, Marder K, Roose SP, Sackeim HA, Stern Y. P1-409 The risk of dementia in sertraline treated elderly patients with depression and cognitive impairment Neurobiology of Aging. 25: S215. DOI: 10.1016/S0197-4580(04)80721-8 |
0.477 |
|
| 2004 |
Tabert MH, Goodkind M, Pelton GH, Vignier M, Zamora D, Marder K, Stern Y, Devanand DP. P1-067 Predictive utility of five neuropsychological measures in outpatients with mild cognitive impairment Neurobiology of Aging. 25: S114. DOI: 10.1016/S0197-4580(04)80381-6 |
0.447 |
|
| 2003 |
Albert SM, Flater SR, Clouse R, Todak G, Stern Y, Marder K. Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. Aids and Behavior. 7: 329-38. PMID 14586194 DOI: 10.1023/A:1025404105378 |
0.416 |
|
| 2003 |
Grove M, Vonsattel JP, Mazzoni P, Marder K. Huntington's disease. Science of Aging Knowledge Environment : Sage Ke. 2003: dn3. PMID 14586062 DOI: 10.1126/Sageke.2003.43.Dn3 |
0.409 |
|
| 2003 |
Louis ED, Levy G, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology. 61: 931-6. PMID 14557562 DOI: 10.1212/Wnl.61.7.931 |
0.464 |
|
| 2003 |
Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Familial aggregation of early- and late-onset Parkinson's disease. Annals of Neurology. 54: 507-13. PMID 14520664 DOI: 10.1002/Ana.10711 |
0.542 |
|
| 2003 |
Klein C, Hedrich K, Wellenbrock C, Kann M, Harris J, Marder K, Lang AE, Schwinger E, Ozelius LJ, Vieregge P, Pramstaller PP, Kramer PL. Frequency of parkin mutations in late-onset Parkinson's disease. Annals of Neurology. 54: 415-6; author reply . PMID 12953277 DOI: 10.1002/Ana.10737 |
0.385 |
|
| 2003 |
Caccappolo-van Vliet E, Miozzo M, Marder K, Stern Y. Where do perseverations come from? Neurocase. 9: 297-307. PMID 12925943 DOI: 10.1076/Neur.9.4.297.15550 |
0.471 |
|
| 2003 |
Holtzer R, Wegesin DJ, Albert SM, Marder K, Bell K, Albert M, Brandt J, Stern Y. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. Archives of Neurology. 60: 1137-42. PMID 12925372 DOI: 10.1001/Archneur.60.8.1137 |
0.522 |
|
| 2003 |
Vliet EC, Manly J, Tang MX, Marder K, Bell K, Stern Y. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline. Journal of the International Neuropsychological Society : Jins. 9: 720-32. PMID 12901778 DOI: 10.1017/S1355617703950053 |
0.51 |
|
| 2003 |
Clark LN, Levy G, Tang MX, Mejia-Santana H, Ciappa A, Tycko B, Cote LJ, Louis ED, Mayeux R, Marder K. The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neuroscience Letters. 347: 17-20. PMID 12865131 DOI: 10.1016/S0304-3940(03)00635-9 |
0.55 |
|
| 2003 |
Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Accuracy of family history data on Parkinson's disease. Neurology. 61: 18-23. PMID 12847150 DOI: 10.1212/01.Wnl.0000074784.35961.C0 |
0.527 |
|
| 2003 |
Holtzer R, Tang MX, Devanand DP, Albert SM, Wegesin DJ, Marder K, Bell K, Albert M, Brandt J, Stern Y. Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. Journal of the American Geriatrics Society. 51: 953-60. PMID 12834515 DOI: 10.1046/J.1365-2389.2003.51308.X |
0.535 |
|
| 2003 |
Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG. Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology. 60: 1467-73. PMID 12743233 DOI: 10.1212/01.Wnl.0000064172.46685.82 |
0.479 |
|
| 2003 |
Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. Predictors of nursing home placement in Huntington disease. Neurology. 60: 998-1001. PMID 12654967 DOI: 10.1212/01.Wnl.0000052992.58107.67 |
0.364 |
|
| 2003 |
Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell KL, Sackeim HA, Van Heertum RL, Moeller JR, Stern Y. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Archives of Neurology. 60: 359-65. PMID 12633147 DOI: 10.1001/Archneur.60.3.359 |
0.51 |
|
| 2003 |
Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C, Shults C, Marder K, Conneally PM, Nichols WC. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology. 60: 796-801. PMID 12629236 DOI: 10.1212/01.Wnl.0000049470.00180.07 |
0.396 |
|
| 2003 |
Anderson KE, Marder KS. An overview of psychiatric symptoms in Huntington's disease. Current Psychiatry Reports. 3: 379-88. PMID 11559474 DOI: 10.1007/S11920-996-0030-2 |
0.322 |
|
| 2002 |
Levy G, Tang MX, Louis ED, Côté LJ, Alfaro B, Mejia H, Stern Y, Marder K. The association of incident dementia with mortality in PD. Neurology. 59: 1708-13. PMID 12473757 DOI: 10.1212/01.Wnl.0000036610.36834.E0 |
0.519 |
|
| 2002 |
Levy G, Jacobs DM, Tang MX, Côté LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K. Memory and executive function impairment predict dementia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1221-6. PMID 12465060 DOI: 10.1002/Mds.10280 |
0.581 |
|
| 2002 |
Marder K, Sandler S, Lechich A, Klager J, Albert SM. Relationship between CAG repeat length and late-stage outcomes in Huntington's disease. Neurology. 59: 1622-4. PMID 12451208 DOI: 10.1212/01.Wnl.0000035627.16789.23 |
0.33 |
|
| 2002 |
Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology. 59: 1568-73. PMID 12451199 DOI: 10.1212/01.Wnl.0000034177.47015.Da |
0.334 |
|
| 2002 |
Kock N, Müller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, et al. Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism. Annals of Neurology. 52: 257-8; author reply . PMID 12210804 DOI: 10.1002/Ana.10270 |
0.478 |
|
| 2002 |
Marder K, Logroscino G. The ever-stimulating association of smoking and coffee and Parkinson's disease. Annals of Neurology. 52: 261-2. PMID 12205636 DOI: 10.1002/Ana.10315 |
0.331 |
|
| 2002 |
Marder K. Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial. Current Neurology and Neuroscience Reports. 2: 390-1. PMID 12169217 DOI: 10.1007/S11910-002-0063-9 |
0.397 |
|
| 2002 |
Marder K. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Current Neurology and Neuroscience Reports. 2: 389-90. PMID 12169216 DOI: 10.1007/S11910-002-0062-X |
0.388 |
|
| 2002 |
Brickman AM, Riba A, Bell K, Marder K, Albert M, Brandt J, Stern Y. Longitudinal assessment of patient dependence in Alzheimer disease Archives of Neurology. 59: 1304-1308. PMID 12164728 DOI: 10.1001/Archneur.59.8.1304 |
0.502 |
|
| 2002 |
Louis ID, Marder K, Jurewicz EC, Watner D, Levy G, Mejia-Santana H. Body mass index in essential tremor Archives of Neurology. 59: 1273-1277. PMID 12164723 DOI: 10.1001/Archneur.59.8.1273 |
0.301 |
|
| 2002 |
Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 513-7. PMID 12112199 DOI: 10.1002/Mds.10119 |
0.568 |
|
| 2002 |
Levy G, Schupf N, Tang MX, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Annals of Neurology. 51: 722-9. PMID 12112078 DOI: 10.1002/Ana.10219 |
0.546 |
|
| 2002 |
Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 58: 1764-8. PMID 12084874 DOI: 10.1212/Wnl.58.12.1764 |
0.316 |
|
| 2002 |
Galasko D, Marder K. Picking away at frontotemporal dementia. Neurology. 58: 1585-6. PMID 12058081 DOI: 10.1212/Wnl.58.11.1585 |
0.353 |
|
| 2002 |
Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 58: 1239-46. PMID 11971093 DOI: 10.1212/Wnl.58.8.1239 |
0.417 |
|
| 2002 |
Scarmeas N, Brandt J, Albert M, Devanand DP, Marder K, Bell K, Ciappa A, Tycko B, Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology. 58: 1182-8. PMID 11971084 DOI: 10.1212/Wnl.58.8.1182 |
0.504 |
|
| 2002 |
Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology. 8: 136-42. PMID 11935465 DOI: 10.1080/13550280290049615 |
0.393 |
|
| 2002 |
Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 250-7. PMID 11921109 DOI: 10.1002/Mds.10086 |
0.561 |
|
| 2001 |
Scarmeas N, Chin SS, Marder K. Cortical basal ganglionic degeneration. Science of Aging Knowledge Environment : Sage Ke. 2001: dn1. PMID 14602941 DOI: 10.1126/Sageke.2001.1.Dn1 |
0.367 |
|
| 2001 |
Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Archives of Neurology. 58: 1630-4. PMID 11594921 DOI: 10.1001/Archneur.58.10.1630 |
0.576 |
|
| 2001 |
Anderson KE, Louis ED, Stern Y, Marder KS. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. The American Journal of Psychiatry. 158: 799-801. PMID 11329405 DOI: 10.1176/Appi.Ajp.158.5.799 |
0.497 |
|
| 2001 |
Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder KS. Factors associated with incident human immunodeficiency virus-dementia. Archives of Neurology. 58: 473-9. PMID 11255452 DOI: 10.1001/Archneur.58.3.473 |
0.501 |
|
| 2001 |
Stern Y, Jacobs D, Goldman J, Gomez-Tortosa E, Hyman BT, Liu Y, Troncoso J, Marder K, Tang MX, Brandt J, Albert M. An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease. Archives of Neurology. 58: 460-5. PMID 11255450 DOI: 10.1001/Archneur.58.3.460 |
0.524 |
|
| 2001 |
Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S. Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology. 56: 415-8. PMID 11171916 DOI: 10.1212/Wnl.56.3.415 |
0.467 |
|
| 2001 |
Kieburtz K, Penney JB, Corno P, Ranen N, Shoulson I, Feigin A, Abwender D, Greenarnyre JT, Higgins D, Marshall FJ, Goldstein J, Steinberg K, Shih C, Richard I, Hickey C, ... ... Marder K, et al. Unified huntington’s disease rating scale: Reliability and consistency Neurology. 11: 136-142. PMID 8684382 DOI: 10.1002/Mds.870110204 |
0.3 |
|
| 2001 |
Albert SM, Jacobs DM, Sano M, Marder K, Bell K, Devanand D, Brandt J, Albert M, Stern Y. Longitudinal Study of Quality of Life in People with Advanced Alzheimer's Disease The American Journal of Geriatric Psychiatry. 9: 160-168. DOI: 10.1097/00019442-200105000-00008 |
0.534 |
|
| 2000 |
Stern Y, Moeller JR, Anderson KE, Luber B, Zubin NR, DiMauro AA, Park A, Campbell CE, Marder K, Bell K, Van Heertum R, Sackeim HA. Different brain networks mediate task performance in normal aging and AD: defining compensation. Neurology. 55: 1291-7. PMID 11087770 DOI: 10.1212/Wnl.55.9.1291 |
0.344 |
|
| 2000 |
Massoud F, Devi G, Moroney JT, Stern Y, Lawton A, Bell K, Marder K, Mayeux R. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study. Journal of the American Geriatrics Society. 48: 1204-10. PMID 11037005 DOI: 10.1111/J.1532-5415.2000.Tb02591.X |
0.609 |
|
| 2000 |
Louis ED, Anderson KE, Moskowitz C, Thorne DZ, Marder K. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Archives of Neurology. 57: 1326-30. PMID 10987900 DOI: 10.1001/Archneur.57.9.1326 |
0.314 |
|
| 2000 |
Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. The American Journal of Psychiatry. 157: 1399-405. PMID 10964854 DOI: 10.1176/Appi.Ajp.157.9.1399 |
0.633 |
|
| 2000 |
Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K. Motor impairment in PD: relationship to incident dementia and age. Neurology. 55: 539-44. PMID 10953188 DOI: 10.1212/Wnl.55.4.539 |
0.451 |
|
| 2000 |
Marder K, Sano M. Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman to do? Neurology. 54: 2035-7. PMID 10851358 DOI: 10.1212/Wnl.54.11.2035 |
0.317 |
|
| 2000 |
Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in Huntington's disease. Experimental Neurology. 163: 136-48. PMID 10785452 DOI: 10.1006/Exnr.2000.7348 |
0.321 |
|
| 2000 |
Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurology. 54: 703-9. PMID 10680807 DOI: 10.1212/Wnl.54.3.703 |
0.506 |
|
| 2000 |
Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology. 54: 452-8. PMID 10668713 DOI: 10.1212/Wnl.54.2.452 |
0.373 |
|
| 2000 |
Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K. Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology. 54: 233-5. PMID 10636157 DOI: 10.1212/Wnl.54.1.233 |
0.324 |
|
| 2000 |
Devi G, Ottman R, Tang MX, Marder K, Stern Y, Mayeux R. Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Archives of Neurology. 57: 72-7. PMID 10634451 DOI: 10.1001/Archneur.57.1.72 |
0.569 |
|
| 2000 |
Louis ED, Marder K, Moskowitz C, Greene P. Arm elevation in Huntington's disease: dystonia or levitation? Movement Disorders : Official Journal of the Movement Disorder Society. 14: 1035-8. PMID 10584685 DOI: 10.1002/1531-8257(199911)14:6<1035::Aid-Mds1023>3.0.Co;2-D |
0.375 |
|
| 2000 |
Devanand DP, Marder K, Stern Y, Pelton GH, Mayeux R. Olfactory deficits in mold cognitive impairment predict Alzheimer's disease on follow-up Neurobiology of Aging. 21: 271. DOI: 10.1016/S0197-4580(00)83174-7 |
0.595 |
|
| 1999 |
Devi G, Ottman R, Tang M, Marder K, Stern Y, Tycko B, Mayeux R. Influence of APOE genotype on familial aggregation of AD in an urban population. Neurology. 53: 789-94. PMID 10489042 DOI: 10.1212/Wnl.53.4.789 |
0.522 |
|
| 1999 |
Albert SM, Michaels K, Padilla M, Pelton G, Bell K, Marder K, Stern Y, Devanand DP. Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 7: 213-20. PMID 10438692 DOI: 10.1097/00019442-199908000-00005 |
0.499 |
|
| 1999 |
Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K, Small S, Epstein LG. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. Neurology. 53: 391-6. PMID 10430432 DOI: 10.1212/Wnl.53.2.391 |
0.335 |
|
| 1999 |
Dolezal C, Meyer-Bahlburg HF, Liu X, Ehrhardt AA, Exner TM, Rabkin JG, Gorman JM, Marder K, Stern Y. Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users. The American Journal of Drug and Alcohol Abuse. 25: 281-303. PMID 10395161 DOI: 10.1081/Ada-100101861 |
0.416 |
|
| 1999 |
Jacobs DM, Albert SM, Sano M, del Castillo-Castañeda C, Paik MC, Marder K, Bell K, Brandt J, Albert MS, Stern Y. Assessment of cognition in advanced AD: the test for severe impairment. Neurology. 52: 1689-91. PMID 10331701 DOI: 10.1212/Wnl.52.8.1689 |
0.487 |
|
| 1999 |
Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson disease. Archives of Neurology. 56: 334-7. PMID 10190824 DOI: 10.1001/Archneur.56.3.334 |
0.41 |
|
| 1999 |
Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Louis E, Stern Y, Mayeux R. Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology. 52: 719-24. PMID 10078716 DOI: 10.1212/Wnl.52.4.719 |
0.63 |
|
| 1999 |
Louis ED, Lee P, Quinn L, Marder K. Dystonia in Huntington's disease: prevalence and clinical characteristics. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 95-101. PMID 9918350 DOI: 10.1002/1531-8257(199901)14:1<95::Aid-Mds1016>3.0.Co;2-8 |
0.369 |
|
| 1999 |
Albert SM, Weber CM, Todak G, Polanco C, Clouse R, McElhiney M, Rabkin J, Stern Y, Marder K. An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication adherence outcomes Aids and Behavior. 3: 121-128. DOI: 10.1023/A:1025483806464 |
0.421 |
|
| 1998 |
Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. The American Journal of Psychiatry. 155: 1512-20. PMID 9812111 DOI: 10.1176/Ajp.155.11.1512 |
0.424 |
|
| 1998 |
Dolezal C, Ehrhardt AA, Meyer-Bahlburg HF, Liu X, Exner TM, Rabkin JG, Gorman JM, Marder K, Stern Y. Sexual risk behavior changes among HIV+ and HIV-female injecting drug users over 4 years. Women & Health. 27: 1-17. PMID 9796081 DOI: 10.1300/J013V27N04_01 |
0.424 |
|
| 1998 |
Mirel DB, Marder K, Graziano J, Freyer G, Zhao Q, Mayeux R, Wilhelmsen KC. Characterization of the human mitochondrial aconitase gene (ACO2). Gene. 213: 205-18. PMID 9630632 DOI: 10.1016/S0378-1119(98)00188-7 |
0.44 |
|
| 1998 |
Devi G, Marder K, Schofield PW, Tang MX, Stern Y, Mayeux R. Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's disease. Genetic Epidemiology. 15: 215-23. PMID 9593109 DOI: 10.1002/(Sici)1098-2272(1998)15:3<215::Aid-Gepi1>3.0.Co;2-3 |
0.584 |
|
| 1998 |
Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Jacobs D, Stern Y, Sano M, Mayeux R. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology. 50: 1141-3. PMID 9566410 DOI: 10.1212/Wnl.50.4.1141 |
0.642 |
|
| 1998 |
Marder K, Logroscino G, Tang MX, Graziano J, Cote L, Louis E, Alfaro B, Mejia H, Slavkovich V, Mayeux R. Systemic iron metabolism and mortality from Parkinson's disease. Neurology. 50: 1138-40. PMID 9566409 DOI: 10.1212/Wnl.50.4.1138 |
0.491 |
|
| 1998 |
Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. Jama. 279: 751-5. PMID 9508150 DOI: 10.1001/Jama.279.10.751 |
0.584 |
|
| 1998 |
Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B, Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 50: 368-73. PMID 9484355 DOI: 10.1212/Wnl.50.2.368 |
0.487 |
|
| 1998 |
Marder K, Logroscino G, Alfaro B, Mejia H, Halim A, Louis E, Cote L, Mayeux R. Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology. 50: 279-81. PMID 9443493 DOI: 10.1212/Wnl.50.1.279 |
0.519 |
|
| 1998 |
STERN Y, TANG M, JACOBS DM, SANO M, MARDER K, BELL K, DOONEIEF G, SCHOFIELD P, CÔTÉ L. Prospective comparative study of the evolution of probable
Alzheimer's disease and Parkinson's disease dementia Journal of the International Neuropsychological Society. 4: 279-284. DOI: 10.1017/S1355617798002793 |
0.587 |
|
| 1997 |
Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, LoIacono N, Cote L, Mayeux R. Altered systemic iron metabolism in Parkinson's disease. Neurology. 49: 714-7. PMID 9305329 DOI: 10.1212/Wnl.49.3.714 |
0.338 |
|
| 1997 |
Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y. Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology. 49: 38-43. PMID 9222167 DOI: 10.1212/Wnl.49.1.38 |
0.484 |
|
| 1997 |
Schofieid PW, Jacobs D, Marder K, Sana M, Stem Y. The validity of new memory complaints in the elderly Archives of Neurology. 54: 756-759. PMID 9193211 DOI: 10.1001/Archneur.1997.00550180064014 |
0.351 |
|
| 1997 |
Wilhelmsen K, Mirel D, Marder K, Bernstein M, Naini A, Leal SM, Cote LJ, Tang MX, Freyer G, Graziano J, Mayeux R. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13? Annals of Neurology. 41: 813-7. PMID 9189044 DOI: 10.1002/Ana.410410619 |
0.51 |
|
| 1997 |
Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology. 41: 615-20. PMID 9153523 DOI: 10.1002/Ana.410410510 |
0.615 |
|
| 1997 |
Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y. Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. The American Journal of Psychiatry. 154: 609-15. PMID 9137114 DOI: 10.1176/Ajp.154.5.609 |
0.445 |
|
| 1997 |
Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry. 54: 257-63. PMID 9075466 DOI: 10.1001/Archpsyc.1997.01830150083012 |
0.52 |
|
| 1997 |
Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Archives of Neurology. 54: 260-4. PMID 9074394 DOI: 10.1001/Archneur.1997.00550150024011 |
0.515 |
|
| 1997 |
Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. Jama. 277: 806-12. PMID 9052710 DOI: 10.1001/Jama.1997.03540340040030 |
0.485 |
|
| 1997 |
Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, Sano M, Stern Y, Mayeux R. Alzheimer's disease after remote head injury: an incidence study. Journal of Neurology, Neurosurgery, and Psychiatry. 62: 119-24. PMID 9048710 DOI: 10.1136/Jnnp.62.2.119 |
0.536 |
|
| 1997 |
Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Reply from the Authors: Preclinical AD Neurology. 48: 549-550. DOI: 10.1212/Wnl.48.2.549-C |
0.485 |
|
| 1997 |
Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R. Reply from the Authors: Early frontal impairment as a predictor of dementia in Parkinson's disease Neurology. 48: 547-547. DOI: 10.1212/Wnl.48.2.547 |
0.596 |
|
| 1997 |
Tang M, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of Oestrogen During Menopause on Risk and Age at Onset of Alzheimer's Disease Obstetrical & Gynecological Survey. 52: 37-39. DOI: 10.1097/00006254-199701000-00020 |
0.601 |
|
| 1996 |
Dooneief GH, Bello JA, Todak GG, Tang MX, Marder KS, Stern Y, Mayeux RP. Serial MRI in HIV Infection With and Without Neurologic Impairment. Journal of Neuro-Aids. 1: 49-57. PMID 16873178 DOI: 10.1300/J128V01N04_05 |
0.482 |
|
| 1996 |
Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. Archives of Neurology. 53: 1121-6. PMID 8912485 DOI: 10.1001/Archneur.1996.00550110061013 |
0.518 |
|
| 1996 |
Albert SM, Del Castillo-Castaneda C, Sano M, Jacobs DM, Marder K, Bell K, Bylsma F, Lafleche G, Brandt J, Albert M, Stern Y. Quality of life in patients with Alzheimer's disease as reported by patient proxies. Journal of the American Geriatrics Society. 44: 1342-7. PMID 8909350 DOI: 10.1111/J.1532-5415.1996.Tb01405.X |
0.473 |
|
| 1996 |
Louis ED, Marder K, Cote L, Wilder D, Tang MX, Lantigua R, Gurland B, Mayeux R. Prevalence of a history of shaking in persons 65 years of age and older: diagnostic and functional correlates. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 63-9. PMID 8771069 DOI: 10.1002/mds.870110112 |
0.443 |
|
| 1996 |
Tang MX, Tsai WY, Marder K, Mayeux R. Linear rank tests for doubly censored data. Statistics in Medicine. 14: 2555-63. PMID 8746888 DOI: 10.1002/Sim.4780142305 |
0.448 |
|
| 1996 |
Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP, Stern Y, Mayeux R. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology. 47: 256-9. PMID 8710089 DOI: 10.1212/Wnl.47.1.256 |
0.575 |
|
| 1996 |
Marder K, Tang MX, Mejia H, Alfaro B, Côté L, Louis E, Groves J, Mayeux R. Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology. 47: 155-60. PMID 8710070 DOI: 10.1212/WNL.47.1.155 |
0.488 |
|
| 1996 |
Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (London, England). 348: 429-32. PMID 8709781 DOI: 10.1016/S0140-6736(96)03356-9 |
0.615 |
|
| 1996 |
Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 185-92. PMID 8684390 DOI: 10.1002/Mds.870110212 |
0.549 |
|
| 1996 |
Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai WY. Application of a growth curve approach to modeling the progression of Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: M179-84. PMID 8681001 DOI: 10.1093/Gerona/51A.4.M179 |
0.521 |
|
| 1996 |
Dooneief G, Marder K, Tang MX, Stern Y. The Clinical Dementia Rating scale: community-based validation of "profound' and "terminal' stages. Neurology. 46: 1746-9. PMID 8649584 DOI: 10.1212/Wnl.46.6.1746 |
0.454 |
|
| 1996 |
Dooneief G, Marlink R, Bell K, Marder K, Renjifo B, Stern Y, Mayeux R. Neurologic consequences of HTLV-II infection in injection-drug users. Neurology. 46: 1556-60. PMID 8649548 DOI: 10.1212/Wnl.46.6.1556 |
0.522 |
|
| 1996 |
Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Annals of Neurology. 39: 89-94. PMID 8572672 DOI: 10.1002/Ana.410390113 |
0.51 |
|
| 1996 |
Stern Y, Liu X, Marder K, Todak G, Sano M, Malouf R, Joseph M, El-Sadr WM, Ehrhardt AA, Williams JBW, Gorman JM. Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV Neuropsychiatry Neuropsychology and Behavioral Neurology. 9: 83-90. DOI: 10.7916/D8Kp9Jkv |
0.453 |
|
| 1995 |
Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Lantigua R, Wilder D, Gurland B, Stern Y, Mayeux R. Consistency of clinical diagnosis in a community-based longitudinal study of dementia and Alzheimer's disease. Neurology. 45: 2159-64. PMID 8848185 DOI: 10.1212/Wnl.45.12.2159 |
0.617 |
|
| 1995 |
Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 44: 2300-7. PMID 7991116 DOI: 10.1212/Wnl.44.12.2300 |
0.537 |
|
| 1995 |
Stern Y, Liu X, Marder K, Todak G, Sano M, Ehrhardt A, Gorman J. Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection. Neurology. 45: 467-72. PMID 7898698 DOI: 10.1212/Wnl.45.3.467 |
0.454 |
|
| 1995 |
Marder K, Liu X, Stern Y, Dooneief G, Bell K, Schofield P, Sacktor N, Todak G, Friedman R, Ehrhardt A. Neurologic signs and symptoms in a cohort of homosexual men followed for 4.5 years. Neurology. 45: 261-7. PMID 7854523 DOI: 10.1212/Wnl.45.2.261 |
0.453 |
|
| 1995 |
Marder K, Richards M, Bello J, Bell K, Sano M, Miller L, Folstein M, Albert M, Stern Y. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Archives of Neurology. 52: 146-51. PMID 7848122 DOI: 10.1001/Archneur.1995.00540260050015 |
0.505 |
|
| 1995 |
Sacktor N, Prohovnik I, Van Heertum RL, Dooneief G, Gorman J, Marder K, Todak G, Stern Y, Mayeux R. Cerebral single-photon emission computed tomography abnormalities in human immunodeficiency virus type 1-infected gay men without cognitive impairment. Archives of Neurology. 52: 607-11. PMID 7763210 DOI: 10.1001/Archneur.1995.00540300081017 |
0.552 |
|
| 1995 |
Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology. 45: 957-62. PMID 7746414 DOI: 10.1212/Wnl.45.5.957 |
0.516 |
|
| 1995 |
Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Archives of Neurology. 52: 525-30. PMID 7733849 DOI: 10.1001/Archneur.1995.00540290115027 |
0.443 |
|
| 1995 |
Jacobs DM, Marder K, Côté LJ, Sano M, Stern Y, Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology. 45: 1691-6. PMID 7675228 DOI: 10.1212/Wnl.45.9.1691 |
0.661 |
|
| 1995 |
Marder K, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Archives of Neurology. 52: 695-701. PMID 7619026 DOI: 10.1001/Archneur.1995.00540310069018 |
0.641 |
|
| 1995 |
Sacktor N, Liu X, Popescu M, Marder K, Stern Y, Mayeux R. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users. Archives of Neurology. 52: 676-9. PMID 7619023 DOI: 10.1001/Archneur.1995.00540310046015 |
0.543 |
|
| 1995 |
Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Archives of Neurology. 52: 961-6. PMID 7575223 DOI: 10.1001/Archneur.1995.00540340045012 |
0.412 |
|
| 1995 |
Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. American Journal of Epidemiology. 142: 820-7. PMID 7572958 DOI: 10.1093/Oxfordjournals.Aje.A117721 |
0.501 |
|
| 1995 |
Louis ED, Marder K, Cote L, Pullman S, Ford B, Wilder D, Tang MX, Lantigua R, Gurland B, Mayeux R. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Archives of Neurology. 52: 1201-5. PMID 7492295 DOI: 10.1001/Archneur.1995.00540360079019 |
0.42 |
|
| 1995 |
Marder K, Liu X, Stern Y, Malouf R, Dooneief G, Bell K, Todak G, Joseph M, Sorrell S, el Sadr W. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users. Archives of Neurology. 52: 1174-82. PMID 7492292 DOI: 10.1001/Archneur.1995.00540360052016 |
0.458 |
|
| 1995 |
Sacktor N, Van Heertum RL, Dooneief G, Gorman J, Khandji A, Marder K, Nour R, Todak G, Stern Y, Mayeux R. A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment. Archives of Neurology. 52: 1170-3. PMID 7492291 DOI: 10.1001/Archneur.1995.00540360048015 |
0.533 |
|
| 1995 |
Marder K, Alfaro B, Maestre G, Halim A, Cote L, Tang M, Mejia H, Tycko B, Mayeux R. Apolipoprotein E4 in Parkinson's disease Neurology. 45: 1025-1025. DOI: 10.1212/WNL.45.5.1025-b |
0.44 |
|
| 1994 |
Mayeux R, Tang MX, Marder K, Côté LJ, Stern Y. Smoking and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 207-12. PMID 8196685 DOI: 10.1002/Mds.870090215 |
0.559 |
|
| 1994 |
Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination Movement Disorders. 9: 89-91. PMID 8139610 DOI: 10.1002/Mds.870090114 |
0.471 |
|
| 1994 |
Richards M, Marder K, Cote L, Mayeux R. Reliability of symptom onset assessment in Parkinson's disease Movement Disorders. 9: 340-342. PMID 8041376 DOI: 10.1002/Mds.870090313 |
0.482 |
|
| 1994 |
Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, Tang M, Tycko B, Mayeux R. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology. 44: 1330-1. PMID 8035940 DOI: 10.1212/Wnl.44.7.1330 |
0.57 |
|
| 1994 |
Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 44: 1215-20. PMID 8035918 DOI: 10.1212/Wnl.44.7.1215 |
0.537 |
|
| 1994 |
Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44: 1878-84. PMID 7936241 DOI: 10.1212/Wnl.44.10.1878 |
0.515 |
|
| 1994 |
Stern Y, Mayeux R, Marder K. Dementia in Parkinson's disease Neurology. 44: 1553-1553. DOI: 10.1212/Wnl.44.8.1553-A |
0.641 |
|
| 1994 |
Albert SM, Todak G, Elkin E, Marder K, Dooneief G, Stern Y. Time allocation and disability in HIV infection: A correlational study Journal of Occupational Science. 1: 21-30. DOI: 10.1080/14427591.1994.9686389 |
0.462 |
|
| 1993 |
Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives Annals of Neurology. 33: 494-501. PMID 8498827 DOI: 10.1002/Ana.410330513 |
0.574 |
|
| 1993 |
Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Annals of Neurology. 33: 267-74. PMID 8498810 DOI: 10.1002/Ana.410330307 |
0.588 |
|
| 1993 |
Stern Y, Folstein M, Albert M, Richards M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Disease and Associated Disorders. 7: 3-21. PMID 8481224 DOI: 10.1097/00002093-199307010-00002 |
0.54 |
|
| 1993 |
Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M, Devanand D. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Disease and Associated Disorders. 7: 22-32. PMID 8481223 DOI: 10.1097/00002093-199307010-00003 |
0.442 |
|
| 1993 |
Sano M, Bell K, Marder K, Stricks L, Stern Y, Mayeux R. Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease. Clinical Neuropharmacology. 16: 61-9. PMID 8422658 DOI: 10.1097/00002826-199302000-00007 |
0.56 |
|
| 1993 |
Richards M, Bell K, Dooneief G, Marder K, Sano M, Mayeux R, Stern Y. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology. 43: 1708-11. PMID 8414017 DOI: 10.1212/Wnl.43.9.1708 |
0.587 |
|
| 1993 |
Stern Y, Marder K, Tang MX, Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology. 43: 1690-2. PMID 8414013 DOI: 10.1212/Wnl.43.9.1690 |
0.653 |
|
| 1993 |
Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, Richards M, Stein Z, Ehrhardt AA, Gorman JM. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology. 43: 176-82. PMID 8093809 DOI: 10.1212/WNL.43.1_Part_1.176 |
0.526 |
|
| 1992 |
Marder K, Mayeux R. The epidemiology of dementia in patients with Parkinson's disease. Advances in Experimental Medicine and Biology. 295: 439-45. PMID 1776581 DOI: 10.1007/978-1-4757-0145-6_25 |
0.57 |
|
| 1992 |
Dooneief G, Bello J, Todak G, Mun IK, Marder K, Malouf R, Gorman J, Hilal S, Stern Y, Mayeux R. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. Archives of Neurology. 49: 38-43. PMID 1728262 DOI: 10.1001/Archneur.1992.00530250042014 |
0.513 |
|
| 1992 |
Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Archives of Neurology. 49: 492-7. PMID 1580811 DOI: 10.1001/Archneur.1992.00530290076015 |
0.632 |
|
| 1992 |
Devanand DP, Miller L, Richards M, Marder K, Bell K, Mayeux R, Stern Y. The Columbia University Scale for Psychopathology in Alzheimer's disease. Archives of Neurology. 49: 371-6. PMID 1558517 DOI: 10.1001/Archneur.1992.00530280051022 |
0.62 |
|
| 1992 |
Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Archives of Neurology. 49: 305-7. PMID 1536634 DOI: 10.1001/Archneur.1992.00530270125028 |
0.542 |
|
| 1992 |
Marder K, Stern Y, Malouf R, Tang MX, Bell K, Dooneief G, el-Sadr W, Goldstein S, Gorman J, Richards M. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury. Archives of Neurology. 49: 1169-75. PMID 1444884 DOI: 10.1001/Archneur.1992.00530350083023 |
0.42 |
|
| 1992 |
Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Archives of Neurology. 49: 1137-41. PMID 1444880 DOI: 10.1001/Archneur.1992.00530350051019 |
0.609 |
|
| 1992 |
Friedman D, Hamberger M, Stern Y, Marder K. Event-related potentials (ERPs) during repetition priming in Alzheimer's patients and young and older controls. Journal of Clinical and Experimental Neuropsychology. 14: 448-62. PMID 1400911 DOI: 10.1080/01688639208402837 |
0.49 |
|
| 1991 |
Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Archives of Neurology. 48: 1147-9. PMID 1953399 DOI: 10.1001/Archneur.1991.00530230055021 |
0.605 |
|
| 1991 |
Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R. Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology. 41: 1240-3. PMID 1866013 DOI: 10.1212/Wnl.41.8.1240 |
0.643 |
|
| 1991 |
Fernandez-Madrid I, Levy E, Marder K, Frangione B. Codon 618 variant of Alzheimer amyloid gene associated with inherited cerebral hemorrhage. Annals of Neurology. 30: 730-3. PMID 1763898 DOI: 10.1002/Ana.410300516 |
0.309 |
|
| 1991 |
Sano M, Stanley M, Lawton A, Coté L, Williams J, Stern Y, Marder K, Mayeux R. Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's disease. Archives of Neurology. 48: 1052-4. PMID 1718247 DOI: 10.1001/Archneur.1991.00530220072022 |
0.569 |
|
| 1991 |
Stern Y, Marder K, Bell K, Chen J, Dooneief G, Goldstein S, Mindry D, Richards M, Sano M, Williams J. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Archives of General Psychiatry. 48: 131-8. PMID 1671199 DOI: 10.1001/Archpsyc.1991.01810260039006 |
0.432 |
|
| 1991 |
Marder K, Stern Y. Neurological and neuropsychological aspects of HIV infection Current Opinion in Psychiatry. 4: 96-100. DOI: 10.1097/00001504-199102000-00022 |
0.404 |
|
| 1990 |
Sano M, Stern Y, Marder K, Mayeux R. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 230-4. PMID 2388639 DOI: 10.1002/Mds.870050308 |
0.6 |
|
| 1990 |
Marder K, Flood P, Cote L, Mayeux R. A pilot study of risk factors for dementia in Parkinson's disease Movement Disorders. 5: 156-161. PMID 2325678 DOI: 10.1002/Mds.870050212 |
0.545 |
|
| 1990 |
Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, Cote L, Stern Y. An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology. 40: 1513-7. PMID 2215941 DOI: 10.1212/Wnl.40.10.1513 |
0.635 |
|
| 1988 |
Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Archives of Neurology. 45: 260-2. PMID 3341950 DOI: 10.1001/Archneur.1988.00520270034017 |
0.7 |
|
| Show low-probability matches. |